Rchr
J-GLOBAL ID:201401052975226377   Update date: Oct. 24, 2021

SUDA GOKI

スダ ゴウキ | SUDA GOKI
Affiliation and department:
Homepage URL  (1): http://kaken.nii.ac.jp/d/r/20447460.ja.html
Research field  (1): Gastroenterology
Papers (107):
  • Takuya Sho, Goki Suda, Koji Ogawa, Megumi Kimura, Akinori Kubo, Yoshimasa Tokuchi, Takashi Kitagataya, Osamu Maehara, Shunsuke Ohnishi, Taku Shigesawa, et al. Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria. Hepatology research : the official journal of the Japan Society of Hepatology. 2021. 51. 9. 979-989
  • Shuichi Miyamoto, Goki Suda, Marin Ishikawa, Hideyuki Hayashi, Satoshi Nimura, Yoshihiro Matsuno, Ryo Mori, Shigeki Tanishima, Takahiko Kudo, Tomofumi Takagi, et al. Genomic profiling of intestinal/mixed-type superficial non-ampullary duodenal epithelial tumors. JGH open : an open access journal of gastroenterology and hepatology. 2021. 5. 9. 1071-1077
  • Yoshimasa Tokuchi, Goki Suda, Megumi Kimura, Osamu Maehara, Takashi Kitagataya, Akinori Kubo, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, et al. Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals. Scientific reports. 2021. 11. 1. 16616-16616
  • Akinori Kubo, Goki Suda, Megumi Kimura, Osamu Maehara, Yoshimasa Tokuchi, Takashi Kitagataya, Masatsugu Ohara, Ren Yamada, Taku Shigesawa, Kazuharu Suzuki, et al. Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI. Cancers. 2021. 13. 14
  • Sonoe Yoshida, Goki Suda, Masatsugu Ohara, Qingjie Fu, Zijian Yang, Shunichi Hosoda, Megumi Kimura, Kubo Akinori, Yoshimasa Tokuchi, Ren Yamada, et al. Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia. Nutrients. 2021. 13. 7
more...
MISC (234):
  • 大原正嗣, 須田剛生, 重沢拓, 鈴木和治, 中村晃久, 川岸直樹, 中井正人, 荘拓也, 森川賢一, 小川浩司, et al. 肝疾患患者における筋肉量の経時変化の評価はBIA法に比べCT画像を用いた方法が有用である. 肝臓. 2021. 62. Supplement 1
  • 須田剛生, 大原正嗣, 坂本直哉. 日本人におけるpsoas muscle mass index最適cut-off値の検討と肝疾患患者における検討. 日本消化器病学会雑誌(Web). 2021. 118
  • 小川浩司, 中井正人, 荘拓也, 須田剛生, 森川賢一, 坂本直哉. Intrahepatic arterio-venous shunt. 日本臨床. 2021
  • 中井正人, 北潟谷隆, 山田錬, 重沢拓, 鈴木和治, 中村晃久, 梅村真知子, 荘拓也, 須田剛生, 森川賢一, et al. トルバプタン奏効後の再燃と炎症および尿L-FABP値の関連. 肝臓. 2020. 61. Supplement 1
  • 中井正人, 小川浩司, 久保彰則, 得地祐匡, 北潟谷隆, 山田錬, 重沢拓, 荘拓也, 須田剛生, 森川賢一, et al. 肝性脳症の疫学. 日本門脈圧亢進症学会雑誌. 2020. 26. 3
more...
Professional career (1):
  • 医学博士 (東京医科歯科大学)
Work history (1):
  • 2013 - Hokkaido University
Awards (7):
  • 2018 - G-Plus 優秀演題賞
  • 2018 - AASLD 2018 Poster of Distinction
  • 2017 - ウイルス肝炎財団研究奨励賞
  • 2016 - 肝臓病学会研究奨励賞
  • 2015 - Liver Forum in Kyoto 研究奨励賞
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page